The up-regulation of IFI27 associates with COVID-19 symptomatic infection, which was confirmed by recent studies (25,26), but whether the down-regulation of TUBB2A associates with similar clinical scenario requires further confirmation. Here, TUBB2A is linked to COVID-19.